Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
Managed Care rebate contracting between Pharmacy Benefit Mangers (PBM) and drug manufacturers is constantly changing to keep pace with shifting market dynamics. Continuous pressure from government, consolidations within PBMs, patent cliff, and the availability of more generic drugs in the industry have led to a focus on reducing costs from both sides. As a result, contracting strategies between manufacturers and PBMs are becoming more complex and payment terms are more aggressive. Although current industry revenue management systems have flexibility to process most rebate scenarios, manufacturers are facing increased pressure to operate around calculation variations both efficiently and accurately — with or without automated functionality.
Read this white paper to learn more